Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Healthtrust
Citi
Boehringer Ingelheim
QuintilesIMS
Cantor Fitzgerald
US Department of Justice
AstraZeneca
Julphar

Generated: October 19, 2017

DrugPatentWatch Database Preview

HECTOROL Drug Profile

« Back to Dashboard

What is the patent landscape for Hectorol, and when can generic versions of Hectorol launch?

Hectorol is a drug marketed by Genzyme Corp and is included in two NDAs.

The generic ingredient in HECTOROL is doxercalciferol. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the doxercalciferol profile page.

Summary for Tradename: HECTOROL

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list34
Clinical Trials: see list11
Patent Applications: see list241
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HECTOROL at DailyMed

Pharmacology for Tradename: HECTOROL

Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-002Apr 6, 2000APRXYesNo► Subscribe► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-003Jul 13, 2009ABRXYesNo► Subscribe► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-001Apr 6, 2000APRXYesYes► Subscribe► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-002Apr 23, 2004ABRXYesNo► Subscribe► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-001Jun 9, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HECTOROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-002Apr 23, 2004► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-002Apr 6, 2000► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-001Jun 9, 1999► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-001Jun 9, 1999► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-001Apr 6, 2000► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-002Apr 23, 2004► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-003Jul 13, 2009► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE;INJECTION021027-001Apr 6, 2000► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-001Jun 9, 1999► Subscribe► Subscribe
Genzyme Corp
HECTOROL
doxercalciferol
CAPSULE;ORAL020862-001Jun 9, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for HECTOROL

Drugname Dosage Strength RLD Submissiondate
doxercalciferolInjection2 mcg/mL, 1 mL in 2 mL vialHectorol12/28/2011
doxercalciferolCapsules1 mcgHectorol2/12/2010
doxercalciferolCapsules0.5 mcg and 2.5 mcgHectorol3/25/2009
doxercalciferolInjection2 mcg/mL, 2 mL ampulesHectorol10/15/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Merck
Covington
Mallinckrodt
Moodys
Julphar
Medtronic
Argus Health
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot